HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi-Chiang Hsu Selected Research

cucurbitacin E

1/2019The effects of cucurbitacin E on GADD45β-trigger G2/M arrest and JNK-independent pathway in brain cancer cells.
1/2017Inducement of apoptosis by cucurbitacin E, a tetracyclic triterpenes, through death receptor 5 in human cervical cancer cell lines.
9/2014GADD45γ induces G2/M arrest in human pharynx and nasopharyngeal carcinoma cells by cucurbitacin E.
8/2013Cucurbitacin E as inducer of cell death and apoptosis in human oral squamous cell carcinoma cell line SAS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi-Chiang Hsu Research Topics

Disease

29Neoplasms (Cancer)
12/2022 - 10/2007
8Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2017 - 03/2012
5Breast Neoplasms (Breast Cancer)
05/2019 - 09/2012
5Nasopharyngeal Carcinoma
12/2018 - 05/2009
4Glioma (Gliomas)
10/2021 - 01/2012
4Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 10/2007
4Keloid
12/2010 - 06/2006
3Ovarian Neoplasms (Ovarian Cancer)
01/2016 - 06/2013
2Squamous Cell Carcinoma of Head and Neck
12/2022 - 08/2013
2Glioblastoma (Glioblastoma Multiforme)
01/2021 - 10/2010
2Neoplasm Metastasis (Metastasis)
03/2017 - 12/2016
2Carcinoma (Carcinomatosis)
06/2016 - 05/2009
2Adenocarcinoma
11/2014 - 09/2012
2Carcinogenesis
06/2012 - 03/2012
2Infections
06/2012 - 03/2012
1Osteoporosis
08/2021
1Brain Neoplasms (Brain Tumor)
01/2019
1Necrosis
01/2018
1Melanoma (Melanoma, Malignant)
03/2017
1Burns
01/2015
1Atrophy
01/2015
1Neuroblastoma
07/2013
1Diabetic Cardiomyopathies
07/2013
1Cardiomegaly (Heart Hypertrophy)
07/2013
1Hypertrophy
07/2013
1Hypercholesterolemia
03/2013
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2013
1Ductal Carcinoma
09/2012

Drug/Important Bio-Agent (IBA)

6sulforaphaneIBA
05/2019 - 01/2012
6DiarylheptanoidsIBA
09/2012 - 10/2007
5Proteins (Proteins, Gene)FDA Link
09/2016 - 03/2007
4Pharmaceutical PreparationsIBA
08/2021 - 02/2016
4cucurbitacin EIBA
01/2019 - 08/2013
4Cyclin B1IBA
01/2019 - 06/2013
4AntioxidantsIBA
09/2012 - 10/2007
4Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2007 - 06/2006
4CollagenIBA
03/2007 - 06/2006
3Antineoplastic Agents (Antineoplastics)IBA
05/2019 - 06/2015
3Biomarkers (Surrogate Marker)IBA
03/2017 - 01/2014
3isothiocyanic acidIBA
09/2016 - 01/2012
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
07/2013 - 07/2012
3CurcuminIBA
09/2012 - 10/2007
3Collagen Type I (Type I Collagen)IBA
03/2007 - 06/2006
3Transforming Growth Factor beta1 (TGF beta 1)IBA
03/2007 - 01/2007
2bardoxoloneIBA
01/2021 - 01/2021
2TriterpenesIBA
01/2021 - 01/2017
2Simvastatin (Zocor)FDA LinkGeneric
01/2018 - 03/2013
2CyclinsIBA
01/2018 - 03/2013
2CXC ChemokinesIBA
03/2017 - 12/2016
2PolyethyleneimineIBA
12/2016 - 06/2013
2PolymersIBA
12/2016 - 07/2012
2Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
06/2012 - 03/2012
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
06/2012 - 03/2012
2Tissue Inhibitor of Metalloproteinase-1IBA
03/2007 - 01/2007
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
03/2007 - 06/2006
11- (4- methylpiperazin- 1- yl)- 3- (5- nitrofuran- 2- yl)prop- 2- en- 1- oneIBA
12/2022
1Nicotinamide PhosphoribosyltransferaseIBA
12/2022
1Phosphotransferases (Kinase)IBA
10/2021
1Small Molecule LibrariesIBA
08/2021
1(2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oic acid) trifluoroethylamideIBA
01/2021
1thiazolyl blueIBA
05/2019
1Cyclin D2IBA
05/2019
1histone deacetylase 3IBA
05/2019
1angiotensin I (1-7)IBA
12/2018
1Hormones (Hormone)IBA
12/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1Propidium (Propidium Iodide)IBA
01/2018
1CholesterolIBA
01/2018
1Annexin A5IBA
01/2018
1Cyclin D1IBA
01/2018
1Capsaicin (Zostrix)FDA Link
06/2017
1Matrix Metalloproteinases (MMPs)IBA
03/2017
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2017
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
01/2017
1Indicators and Reagents (Reagents)IBA
12/2016
1graphene oxideIBA
12/2016
1Small Interfering RNA (siRNA)IBA
12/2016
1IsothiocyanatesIBA
09/2016
1Conditioned Culture MediaIBA
06/2016
1InterferonsIBA
06/2016
1Cisplatin (Platino)FDA LinkGeneric
02/2016
1MelatoninIBA
01/2016
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2014
1Messenger RNA (mRNA)IBA
11/2014
1hepatoma-derived growth factorIBA
11/2014
1AntigensIBA
01/2014
1GlyceraldehydeIBA
07/2013
1Advanced Glycation End ProductsIBA
07/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2013
12- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
07/2013
1Carbon Nanotubes (Carbon Nanotube)IBA
06/2013
1Poloxamer (Poloxamer 407)IBA
07/2012
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
06/2012

Therapy/Procedure

6Therapeutics
12/2022 - 05/2009
5Drug Therapy (Chemotherapy)
01/2017 - 05/2009
4Radiotherapy
01/2017 - 05/2009
2Hysterectomy
01/2017 - 09/2016
2Chemoprevention
07/2012 - 12/2010
1Aftercare (After-Treatment)
05/2019
1Denervation
01/2015